The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Primary prophylaxis with pegylated-granulocyte colony-stimulating factor for patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: A randomized phase II trial.

Choong-kun  Lee

Honoraria - Boryung; Dong-A ST; Novartis; SERVIER

Consulting or Advisory Role - AstraZeneca

Il-Hwan  Kim

No Relationships to Disclose

Chang Gon  Kim

Consulting or Advisory Role - Amgen; Novartis; Pfizer

Speakers' Bureau - Boehringer Ingelheim; Takeda

Research Funding - Daewoong Pharmaceutical; Yuhan

Hye Jin  Choi

No Relationships to Disclose